Commonly reported side effects of boceprevir include: anemia, dizziness, dyspnea on exertion, and neutropenia.  See below for a comprehensive list of adverse effects.
This drug must be administered in combination with peginterferon alfa and ribavirin.  The manufacturer product information for peginterferon alfa and ribavirin should be consulted for associated side effects.Serious side effects (including anemia and neutropenia) have been reported in 11% of patients receiving boceprevir combination therapy compared to 8% of patients receiving peginterferon alfa plus ribavirin alone.  The side effects reported most frequently were fatigue, anemia, nausea, headache, and dysgeusia.  Therapy was discontinued due to side effects in 13% of patients using boceprevir combination therapy and 12% of patients using peginterferon alfa plus ribavirin alone.  The side effects leading to discontinuation most often were anemia and fatigue.
Decreased hemoglobin (less than 10 g/dL: 49%; less than 8.5 g/dL: up to 10%), decreased neutrophils (less than 0.75 x 10[9]/L: up to 31%; less than 0.5 x 10[9]/L: up to 8%), and decreased platelets (less than 50 x 10[9]/L: up to 4%; less than 25 x 10[9]/L: less than 1%) have been reported.Agranulocytosis, pancytopenia, and thrombocytopenia have also been reported during postmarketing experience.
Very common (10% or more): Anemia (up to 50%), decreased hemoglobin (up to 49%), decreased neutrophils (up to 31%), neutropenia (up to 25%)Common (1% to 10%): Decreased platelets, leukopenia, thrombocytopenia, pancytopenia, agranulocytosisUncommon (0.1% to 1%): Hemorrhagic diathesis, lymphadenopathy, lymphopeniaRare (less than 0.1%): Hemolysis
Frequency not reported: Serious acute hypersensitivity reactions (e.g., urticaria, angioedema)
Very common (10% or more): Fatigue (up to 58%), chills (up to 34%), pyrexia (up to 32%), influenza-like illness (up to 23%), asthenia (up to 21%), decreased weight (11%)Common (1% to 10%): Pain, peripheral edema, chest discomfort, chest pain, malaise, feeling of body temperature change, mucosal drynessUncommon (0.1% to 1%): Feeling abnormal, impaired healing, noncardiac chest pain, staphylococcal infection, candidiasis, ear infection, ear discomfort, flushing, pallor, peripheral coldnessRare (less than 0.1%): Otitis media, sepsis
Sepsis has also been reported during postmarketing experience.
Mouth ulceration and stomatitis have also been reported during postmarketing experience.
Very common (10% or more): Nausea (up to 46%), dysgeusia (up to 44%), diarrhea (up to 25%), vomiting (up to 20%), dry mouth (up to 15%)Common (1% to 10%): Abdominal pain, upper abdominal pain, constipation, gastroesophageal reflux disease, hemorrhoids, abdominal discomfort, abdominal distention, anorectal discomfort, aphthous stomatitis, cheilitis, dyspepsia, flatulence, glossodynia, mouth ulceration, oral pain, stomatitis, tooth disorder, oral fungal infectionUncommon (0.1% to 1%): Lower abdominal pain, gastritis, pancreatitis, anal pruritus, colitis, dysphagia, discolored feces, frequent bowl movements, gingival bleeding, gingival pain, gingivitis, glossitis, dry lip, odynophagia, proctalgia, rectal hemorrhage, salivary hypersecretion, sensitivity of teeth, tongue discoloration, tongue ulceration, gastroenteritisRare (less than 0.1%): Pancreatic insufficiency
Very common (10% or more): Headache (up to 45%), dizziness (up to 19%)Common (1% to 10%): Hypoesthesia, paresthesia, syncope, amnesia, attention disturbance, memory impairment, migraine, parosmia, tremor, vertigo, tinnitusUncommon (0.1% to 1%): Peripheral neuropathy, cognitive disorder, hyperesthesia, lethargy, loss of consciousness, mental impairment, neuralgia, presyncope, deafness, impaired hearingRare (less than 0.1%): Cerebral ischemia, encephalopathy
Very common (10% or more): Insomnia (up to 34%), irritability (up to 22%), depression (up to 21%), anxiety (12%)Common (1% to 10%): Affect lability, agitation, libido disorder, altered mood, sleep disorderUncommon (0.1% to 1%): Aggression, homicidal ideation, panic attack, paranoia, substance abuse, suicidal ideation, abnormal behavior, anger, apathy, confusional state, mental status changes, restlessnessRare (less than 0.1%): Bipolar disorder, completed suicide, suicide attempt, auditory hallucination, visual hallucination, psychiatric decompensation
Very common (10% or more): Alopecia (up to 27%), dry skin (up to 22%), rash (up to 17%)Common (1% to 10%): Dermatitis, eczema, erythema, hyperhidrosis, night sweats, psoriasis, erythematous rash, macular rash, maculopapular rash, papular rash, pruritic rash, skin lesion, cellulitis, herpes simplexUncommon (0.1% to 1%): Photosensitivity reaction, skin ulcer, urticaria, fungal skin infection, onychomycosis, skin infectionPostmarketing reports: Angioedema, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma
Urticaria has also been reported during postmarketing experience.
Very common (10% or more): Decreased appetite/anorexia (up to 26%)Common (1% to 10%): Dehydration, hyperglycemia, hypertriglyceridemia, hyperuricemiaUncommon (0.1% to 1%): Hypokalemia, appetite disorder, diabetes mellitus, gout, hypercalcemiaRare (less than 0.1%): Non-acute porphyriaFrequency not reported: Increased uric acid, increased triglycerides, increased cholesterol
Very common (10% or more): Myalgia (up to 24%), arthralgia (up to 23%)Common (1% to 10%): Back pain, pain in extremity, muscle spasms, muscular weakness, neck painUncommon (0.1% to 1%): Musculoskeletal chest pain, arthritis, bone pain, joint swelling, musculoskeletal pain
Pneumonia has also been reported during postmarketing experience.
Very common (10% or more): Exertional dyspnea (up to 11%), cough, dyspneaCommon (1% to 10%): Bronchitis, influenza, sinusitis, epistaxis, nasal congestion, oropharyngeal pain, respiratory tract congestion, sinus congestion, wheezingUncommon (0.1% to 1%): Pneumonia, nasopharyngitis, pharyngitis, respiratory tract infection, rhinitis, pleuritic pain, pulmonary embolism, dry throat, dysphonia, increased upper airway secretion, oropharyngeal blisteringRare (less than 0.1%): Epiglottitis, pleural fibrosis, orthopnea, respiratory failure
Common (1% to 10%): Palpitations, hypotension, hypertensionUncommon (0.1% to 1%): Cardiac murmur, increased heart rate, tachycardia, arrhythmia, cardiovascular disorder, deep vein thrombosisRare (less than 0.1%): Acute myocardial infarction, atrial fibrillation, coronary artery disease, pericarditis, pericardial effusion, venous thrombosis
Common (1% to 10%): Goiter, hypothyroidismUncommon (0.1% to 1%): Hyperthyroidism
Common (1% to 10%): Pollakiuria, erectile dysfunctionUncommon (0.1% to 1%): Urinary tract infection, dysuria, nocturia, amenorrhea, menorrhagia, metrorrhagiaRare (less than 0.1%): Aspermia
Common (1% to 10%): Dry eye, retinal exudates, blurred vision, visual impairmentUncommon (0.1% to 1%): Retinal ischemia, retinopathy, abnormal sensation in eye, conjunctival hemorrhage, conjunctivitis, eye pain, eye pruritus, eye swelling, eyelid edema, increased lacrimation, ocular hyperemia, photophobiaRare (less than 0.1%): Papilledema
Uncommon (0.1% to 1%): HyperbilirubinemiaRare (less than 0.1%): Cholecystitis
Rare (less than 0.1%): Sarcoidosis
Rare (less than 0.1%): Thyroid neoplasm (nodules)
Black, tarry stools
chills
cough
difficult or labored breathing
fever
lower back or side pain
painful or difficult urination
pale skin
sore throat
tightness in the chest
troubled breathing with exertion
ulcers, sores, or white spots in the mouth
unusual bleeding or bruising
unusual tiredness or weakness
Change in taste
decreased appetite
diarrhea
difficulty with moving
dizziness
dry mouth
dry skin
hair loss or thinning of the hair
irritability
lack or loss of strength
loss of taste
muscle pain or stiffness
nausea
pain in the joints
rash
trouble sleeping
vomiting